| 11/13/2026 3:49 PM | Krystal Biotech (1711279) Issuer ROSSI DINO A (1209059) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/02/2026 6:05 AM | Krystal Biotech (1711279) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/02/2026 6:07 AM | Krystal Biotech (1711279) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/30/2026 12:53 PM | Krystal Biotech (1711279) Subject VANGUARD PORTFOLIO MANAGEMENT LLC (2100121) Filed by | Form SCHEDULE 13G/A | |
| 10/27/2026 4:25 PM | BlackRock, Inc. (2012383) Filed by Krystal Biotech (1711279) Subject | Form SCHEDULE 13G/A | |
| 10/15/2026 6:02 AM | Krystal Biotech (1711279) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/16/2026 7:00 PM | Gangolli Julian S (1532023) Reporting Krystal Biotech (1711279) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/16/2026 7:01 PM | JANNEY DANIEL (1198325) Reporting Krystal Biotech (1711279) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/16/2026 7:01 PM | Krystal Biotech (1711279) Issuer Mason Christopher (1836440) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/16/2026 7:02 PM | Krystal Biotech (1711279) Issuer Mazzacco Catherine (1967722) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/16/2026 7:03 PM | Krystal Biotech (1711279) Issuer Sutherland Everett Rand (1852880) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for KRYS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Krystal Biotech and its competitors with MarketBeat's FREE daily newsletter.
|
| 09/16/2026 7:05 PM | Krystal Biotech (1711279) Issuer ROSSI DINO A (1209059) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/04/2026 6:14 PM | Krishnan Krish S (1298709) Reporting Krystal Biotech (1711279) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/04/2026 6:15 PM | Krishnan Suma (1298711) Reporting Krystal Biotech (1711279) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/04/2026 3:34 PM | Krishnan Krish S (1298709) Reporting Krystal Biotech (1711279) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/04/2026 3:34 PM | Krishnan Suma (1298711) Reporting Krystal Biotech (1711279) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/14/2026 5:22 PM | Krystal Biotech (1711279) Issuer ROSSI DINO A (1209059) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/14/2026 4:21 PM | Krystal Biotech (1711279) Subject ROSSI DINO A (1209059) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/03/2026 6:03 AM | Krystal Biotech (1711279) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/03/2026 6:04 AM | Krystal Biotech (1711279) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/21/2026 4:24 PM | Krystal Biotech (1711279) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/26/2026 5:45 PM | Krystal Biotech (1711279) Issuer Thomas John Charles (2114900) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/25/2026 9:03 AM | Krystal Biotech (1711279) Subject Thomas John Charles (2114900) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/05/2026 5:38 PM | Krishnan Krish S (1298709) Reporting Krystal Biotech (1711279) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/05/2026 5:40 PM | Krishnan Suma (1298711) Reporting Krystal Biotech (1711279) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/04/2026 3:30 PM | Krishnan Krish S (1298709) Reporting Krystal Biotech (1711279) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/04/2026 3:30 PM | Krishnan Suma (1298711) Reporting Krystal Biotech (1711279) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/27/2026 4:17 PM | Krystal Biotech (1711279) Issuer Thomas John Charles (2114900) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/26/2026 9:30 AM | Krystal Biotech (1711279) Subject Thomas John Charles (2114900) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/04/2026 6:10 AM | Krishnan Krish S (1298709) Filed by Krystal Biotech (1711279) Subject | Form SCHEDULE 13G/A | |
| 05/04/2026 6:06 AM | Krystal Biotech (1711279) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/04/2026 6:07 AM | Krystal Biotech (1711279) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/29/2026 1:16 PM | Krystal Biotech (1711279) Subject VANGUARD PORTFOLIO MANAGEMENT LLC (2100121) Filed by | Form SCHEDULE 13G | |
| 04/03/2026 3:34 PM | Krystal Biotech (1711279) Filer | Form ARS | |
| 04/03/2026 3:31 PM | Krystal Biotech (1711279) Filer | Form DEF 14A | |
| 04/03/2026 3:32 PM | Krystal Biotech (1711279) Filer | Form DEFA14A | |
| 03/06/2026 5:22 PM | Krishnan Krish S (1298709) Reporting Krystal Biotech (1711279) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 5:23 PM | Krishnan Suma (1298711) Reporting Krystal Biotech (1711279) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 5:24 PM | Krystal Biotech (1711279) Issuer Thomas John Charles (2114900) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/06/2026 5:26 PM | Goux Laurent Louis Jean (2114613) Reporting Krystal Biotech (1711279) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/04/2026 3:39 PM | Krishnan Krish S (1298709) Reporting Krystal Biotech (1711279) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Why I'm selling my Snapback Indicator for just $7 (Ad) For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indicator for a single $7 payment. Others previously paid $500.
The indicator flashes a Crash Alert as a cue to exit or go short, and a Bull Run Alert as a cue to buy or go long.
No strings attached, and Wood says there is an unusual reason behind the steep discount. Get lifetime access to the Snapback Indicator for a one-time $7 payment today. |
| 03/04/2026 3:40 PM | Krishnan Suma (1298711) Reporting Krystal Biotech (1711279) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/03/2026 5:28 PM | JANNEY DANIEL (1198325) Reporting Krystal Biotech (1711279) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/03/2026 5:30 PM | Krishnan Krish S (1298709) Reporting Krystal Biotech (1711279) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/03/2026 5:33 PM | Krishnan Suma (1298711) Reporting Krystal Biotech (1711279) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/03/2026 5:33 PM | Krystal Biotech (1711279) Issuer ROMANO KATHRYN (1801385) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/02/2026 11:56 AM | Krystal Biotech (1711279) Subject ROMANO KATHRYN (1801385) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/27/2026 3:41 PM | JANNEY DANIEL (1198325) Reporting Krystal Biotech (1711279) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/26/2026 5:49 PM | JANNEY DANIEL (1198325) Reporting Krystal Biotech (1711279) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/24/2026 4:20 PM | JANNEY DANIEL (1198325) Reporting Krystal Biotech (1711279) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/24/2026 3:39 PM | JANNEY DANIEL (1198325) Reporting Krystal Biotech (1711279) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/23/2026 6:14 PM | Krystal Biotech (1711279) Issuer ROSSI DINO A (1209059) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/19/2026 11:09 AM | Krystal Biotech (1711279) Subject ROSSI DINO A (1209059) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/17/2026 6:05 AM | Krystal Biotech (1711279) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 02/17/2026 6:06 AM | Krystal Biotech (1711279) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/11/2026 6:08 PM | Krystal Biotech (1711279) Issuer ROMANO KATHRYN (1801385) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/12/2026 6:50 AM | Krystal Biotech (1711279) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/08/2026 3:35 PM | Krystal Biotech (1711279) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/23/2025 3:51 PM | Krystal Biotech (1711279) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/05/2025 5:53 PM | Krishnan Krish S (1298709) Reporting Krystal Biotech (1711279) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/05/2025 5:56 PM | Krishnan Suma (1298711) Reporting Krystal Biotech (1711279) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/04/2025 3:40 PM | Krishnan Krish S (1298709) Reporting Krystal Biotech (1711279) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/04/2025 3:38 PM | Krishnan Suma (1298711) Reporting Krystal Biotech (1711279) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |